Maynard Um
-
-
-
-
-
-
-
Jefferies on BioAge Labs Inc (BIOA): 'stock setup from here is very attractive'
-
-
-
-
-
-
-
BioAmber (BIOA) Reports Q3 Loss of $0.56
-
-
-
-
-
-
-
BioAge Labs (BIOA) completes IND-enabling studies for BGE-102, a potent, orally available, brain-penetrant NLRP3 inhibitor, and advances candidate toward the clinic
-
-
-
-
-
-
-
BIOA DEADLINE TOMORROW: BioAge Labs Investors are Notified to Contact BFA Law before Tomorrow's March 10 Class Action Deadline
-
-
-
-
-
-
-
BioAge Labs (BIOA) Abandons Obesity Drug Amid Shareholder Lawsuit - Hagens Berman
-
-
-
-
-
-
-
BIOA DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages BioAge Labs, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important March 10 Deadline in Securities Class Action - BIOA
-
-
-
-
-
-
-
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BioAge Labs
-
404,858 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

